Prognostic role of MicroRNA-210 in various carcinomas: A systematic review and meta-analysis

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Li, Minmin ^a   Ma, Xuelei ^a   Li, Mei ^a   Zhang, Binglan ^a   Huang, Juan ^a   Liu, Lei ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 210; MICRORNA; MIRN210 MICRORNA, HUMAN; TUMOR MARKER;

BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOMA; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT RELAPSE FREE SURVIVAL; HEAD AND NECK CANCER; HUMAN; KIDNEY CARCINOMA; META ANALYSIS (TOPIC); METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE FREE SURVIVAL; REVIEW; RNA ANALYSIS; SOFT TISSUE SARCOMA; SYSTEMATIC REVIEW (TOPIC); GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RNA INTERFERENCE; TUMOR RECURRENCE;

CARCINOMA; DISEASE-FREE SURVIVAL; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84893793630     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/106197     Document Type: Review

References (33)

1. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
2. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
3. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
4. Calin G. A., Dumitru C. D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C. M., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15524 15529 2-s2.0-18744396337 10.1073/pnas.242606799 (Pubitemid 35403967)
5. Esquela-Kerscher A., Slack F. J., Oncomirs-microRNAs with a role in cancer. Nature Reviews Cancer 2006 6 4 259 269 2-s2.0-33645294070 10.1038/nrc1840
6. Bushati N., Cohen S. M., MicroRNA functions. Annual Review of Cell and Developmental Biology 2007 23 175 205
7. Croce C. M., Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 2009 10 10 704 714 2-s2.0-70349320158 10.1038/nrg2634
8. Calin G. A., Croce C. M., MicroRNA signatures in human cancers. Nature Reviews Cancer 2006 6 11 857 866 2-s2.0-33750370444 10.1038/nrc1997 (Pubitemid 44629897)
9. Iorio M. V., Ferracin M., Liu C.-G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J. P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G. A., Querzoli P., Negrini M., Croce C. M., MicroRNA gene expression deregulation in human breast cancer. Cancer Research 2005 65 16 7065 7070 2-s2.0-23844555119 10.1158/0008-5472.CAN-05-1783 (Pubitemid 41161233)
10. Nana-Sinkam P., Croce C. M., MicroRNAs in diagnosis and prognosis in cancer: what does the future hold? Pharmacogenomics 2010 11 5 667 669 2-s2.0-77951602461 10.2217/pgs.10.57
11. Ferracin M., Veronese A., Negrini M., Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics 2010 10 3 297 308 2-s2.0-77950625464 10.1586/erm.10.11
12. Huang X., Ding L., Bennewith K. L., Tong R. T., Welford S. M., Ang K. K., Story M., Le Q.-T., Giaccia A. J., Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular Cell 2009 35 6 856 867 2-s2.0-70349168446 10.1016/j.molcel.2009.09.006
13. Chan S. Y., Zhang Y.-Y., Hemann C., Mahoney C. E., Zweier J. L., Loscalzo J., MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metabolism 2009 10 4 273 284 2-s2.0-70349478990 10.1016/j.cmet.2009.08.015
14. Kulshreshtha R., Ferracin M., Wojcik S. E., Garzon R., Alder H., Agosto-Perez F. J., Davuluri R., Liu C.-G., Croce C. M., Negrini M., Calin G. A., Ivan M., A microRNA signature of hypoxia. Molecular and Cellular Biology 2007 27 5 1859 1867 2-s2.0-33847234988 10.1128/MCB.01395-06
15. Fasanaro P., D'Alessandra Y., di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M. C., Martelli F., MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. The Journal of Biological Chemistry 2008 283 23 15878 15883 2-s2.0-47049119934 10.1074/jbc.M800731200
16. Camps C., Buffa F. M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A. L., Gleadle J. M., Ragoussis J., hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 2008 14 5 1340 1348 2-s2.0-40949137731 10.1158/1078-0432.CCR-07-1755 (Pubitemid 351413913)
17. Greither T., Grochola L. F., Udelnow A., Lautenschläger C., Würl P., Taubert H., Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. International Journal of Cancer 2010 126 1 73 80 2-s2.0-73449134501 10.1002/ijc.24687
18. Shuwei Q., Sheng L., Dan H., Interactions of miR-323/miR-326/miR-329and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. Journal of Translational Medicine 2013 11 article 10
19. Gee H. E., Camps C., Buffa F. M., Patiar S., Winter S. C., Betts G., Homer J., Corbridge R., Cox G., West C. M. L., Ragoussis J., Harris A. L., hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010 116 9 2148 2158 2-s2.0-77951463320 10.1002/cncr.25009
20. Neal C. S., Michael M. Z., Rawlings L. H., van der Hoek M. B., Gleadle J. M., The VHL-dependent regulation of microRNAs in renal cancer. BMC Medicine 2010 8 article 64 2-s2.0-77958065302 10.1186/1741-7015-8-64
21. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., Li C., O'Brien-Jenkins A., Katsaros D., Weber B. L., Simon C., Coukos G., Zhang L., miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biology and Therapy 2008 7 2 255 264 2-s2.0-42549092314 (Pubitemid 351590433)
22. Parmar M. K., Torri V., Stewart L., Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998 17 24 2815 2834 (Pubitemid 28562978)
23. Williamson P. R., Smith C. T., Hutton J. L., Marson A. G., Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 2002 21 22 3337 3351 2-s2.0-0037202566 10.1002/sim.1303 (Pubitemid 35314654)
24. Tierney J. F., Stewart L. A., Ghersi D., Burdett S., Sydes M. R., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007 8 article 16 2-s2.0-34547450763 10.1186/1745-6215-8- 16 (Pubitemid 47161711)
25. Hayes D. F., Isaacs C., Stearns V., Prognostic factors in breast cancer: current and new predictors of metastasis. Journal of Mammary Gland Biology and Neoplasia 2001 6 4 375 392 2-s2.0-0035495969 10.1023/A:1014778713034 (Pubitemid 39600496)
26. Huang X., Le Q.-T., Giaccia A. J., miR-210-micromanager of the hypoxia pathway. Trends in Molecular Medicine 2010 16 5 230 237 2-s2.0-77952111459 10.1016/j.molmed.2010.03.004
27. Kulshreshtha R., Ferracin M., Wojcik S. E., Garzon R., Alder H., Agosto-Perez F. J., Davuluri R., Liu C.-G., Croce C. M., Negrini M., Calin G. A., Ivan M., A microRNA signature of hypoxia. Molecular and Cellular Biology 2007 27 5 1859 1867 2-s2.0-33847234988 10.1128/MCB.01395-06
28. Biswas S., Roy S., Banerjee J., Hussain S.-R. A., Khanna S., Meenakshisundaram G., Kuppusamy P., Friedman A., Sen C. K., Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proceedings of the National Academy of Sciences of the United States of America 2010 107 15 6976 6981 2-s2.0-77951043486 10.1073/pnas.1001653107
29. Yuan-Lei L., Fei G., Fen L., miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Molecular and Cellular Biochemistry 2012 370 45 51
30. Liang Y., An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Medical Genomics 2008 1 article 61
31. de Planell-Saguer M., Rodicio M. C., Analytical aspects of microRNA in diagnostics: a review. Analytica Chimica Acta 2011 699 2 134 152 2-s2.0-79959546069 10.1016/j.aca.2011.05.025
32. Wei J., Gao W., Zhu C.-J., Liu Y.-Q., Mei Z., Cheng T., Shu Y.-Q., Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chinese Journal of Cancer 2011 30 6 407 414 2-s2.0-79959298372 10.5732/cjc.010.10522
33. Eun-Jung J., Libero S., Juyeon K., Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 2012 118 10 2603 2614